The Fight Against Alzheimer's; Where Are We Now?
7/31/2022: Scientists around the world, including Rudy Tanzi, PhD, have continued to chip away at the genetic underpinning of this heartbreaking disease that steals the mind, leaving the body empty of its former self.
- Could Getting Your Flu Shot Help Prevent Alzheimer's?
6/29/2022: Time spoke with Child Neurology Resident Avram Bukhbinder, MD about his research, which suggests that dementia prevention may be an additional benefit to geting vaccinated against the flu.
- You Could Have Long COVID and Not Even Know It
6/28/2022: Time Magazine covers work from Leidys Gutierrez-Martinez , MD, MS, Zeina Chemali, MD, MPH and colleagues on the prevalence of post-COVID-19 complications. The research was also covered in Physician's Weekly.
- Silent Symptoms of Dementia Over 50s Need to Know
6/27/2022: Eat This, Not That! speaks with Rudy Tanzi, PhD and other experts about subtle, early symptoms to watch out for.
- How Exercise May Help Prevent Alzheimer's
6/22/2022: PBS discusses research into the hormone irisin, its relationship to exercise, and ways that regular exercise can prevent dementia in addition to its other known health benefits.
- Brain Practices New Tasks While We Sleep
6/22/2022: The Harvard Gazette covers research by Daniel Rubin, MD, PhD and his colleagues at the Center for Neurotechnology and Neurorecovery (CNTR) that gives a glimpse into how our brains operate during sleep.
- New Guidelines Have Some Stroke Patients Dropping Aspirin. That Could Be Dangerous
6/22/2022: Lee Schwamm, MD helps to clarify updated recommendations about the use of low-dose aspirin, noting that it is still quite useful in many cases.
- Assessing and Managing Functional Neurologic Disorders
6/16/2022: David Perez, MD, MSc joins Medscape for a discussion of functional neurological disorder.
- Analysis Shows Predictive Capabilities of Sleep EEG
6/13/2022: Medscape offers additional coverage of sleep diagnostics research by Haoqi Sun, PhD.
- Starting Tofersen Early Slows ALS Progression Better: Trial Data
6/8/2022: A research group including several Healey Center investigators has a new report with promising results on the use of the experimental drug Toferson.
- New Clues Are Revealing Why Exercise Can Keep the Brain Healthy
6/6/2022: National Geographic discusses research by Christiane Wranne, DVM, PhD into the hormone irisin and its connection to cognitive health.
- Brain Wave Sleep Data Can Predict Future Health Outcomes
6/6/2022: Neuroscience News covers research by Brandon Westover, MD, PhD and Haoqi Sun, PhD into the diagnostic potential of sleep monitoring.
- Dr. John Winkelman Emphasizes Importance of Long-term Research on Opioids for Restless Leg Syndrome
6/6/2022: The American Journal of Managed Care interviewed John Winkelman, MD, PhD about long-term studies of the use of opioids for RLS.
- Signs You Have "Vascular Dementia"
5/26/2022: Anand Viswanathan, MD, PhD and other experts spoke with Eat This, Not That! about signs of vascular dementia and ways to prevent it.
- New Clinical Studies In ALS Show Promise
5/24/2022: Clinical Leader highlights advances in ALS research, including the HEALEY ALS Platform Trial and BrainGate.
- New Bleeding Stroke Guidelines Highlight Several Common Treatments that May Be Ineffective
5/17/2022: Cardiovascular Business highlights updates to stroke treatment guidlines from a group led by Mass General Investigator Steve Greenberg, MD, PhD.
- Tim Green Fought ALS Diagnosis Until it Nearly Killed Him, and Now He’s Fighting Back
5/10/2022: The Athletic features a moving profile of NFL star, writer and ALS activist Tim Green and his family.
- ATA2022: What Does the Future Hold for Virtual Care?
5/4/2022: Lee Schwamm, MD spoke about opportunities and obstacles in the future of telemedicine platforms on a panel at the American Telemedicine Association's 2022 conference.
- Hallmarks of Alzheimer’s Found Well Before Diagnosis
5/2/2022: A new study led by investigators at Massachusetts General Hospital shows that early accumulation of amyloid-β and tau protein begins to disrupt the brain’s connections important for memory years before signs of cognitive impairment were observed. The research was also covered in the Boston Globe.
- Merit Cudkowicz Wins Rebecca Luker Courage Award
4/28/2022: Target ALS and Mitsubishi Tanabe Pharma America presented Merit Cudkowicz, MD, MSc with the award in honor of her courageous spirit and positive impact for the ALS community.
- HEALEY ALS Platform Trial Wins Morris ALS Principles Award
4/25/2022: The Morris ALS Principles award honored the HEALEY ALS Platform Trial team for their work to include people with ALS in planning and development of the trial and for using Expanded Access Protocols to give more people access to potential therapies.
- Aversion drummer Mick Palmesano, who died battling ALS, remembered in home town of Hornell
4/18/2022: In memory of Aversion drummer Mick Palmesano, his sister Peggy Polizzi has started a charity devoted to ALS research and assistance to people with ALS; their first fundraiser will be later this month.
- The Medical-Robotics Revolution
4/18/2022: Harvard Magazine covers advances in "soft robotics" for medicine and speaks with Sabrina Paganoni, MD, PhD about their potential for ALS treatment, especially in combination with developments from the BrainGate research led by Leich Hochberg, MD, PhD.
- Long Covid Could Reveal Clues to Alzheimer’s, Lyme Disease
3/16/2022: The Washington Post covers research by Mass General Neurologist Mark Albers, MD, PhD into the neurological changes caused by COVID-19 and ways that they might advance our understanding of other neurological conditions, including Alzheimer's.
- Recovery of Consciousness May Take Weeks for Most COVID Patients on Respirators
3/15/2022: News Medical covers research by Brian Edlow, MD and collaborators, who report that COVID patients often take longer to recover consciousness after intubation than people who are unconscious for other reasons. The research was also covered by the Boston Globe, US News & World Report, MedScape and WTVB Radio.
- What to Know about Amylyx’s ALS Drug and a Highly Anticipated Advisory Panel Meeting
3/14/2022: Sabrina Paganoni, MD, PhD spoke with STAT News about an upcoming hearing on the experimental ALS treatment AMX-0035.
- What Do ALS And War Have In Common?
3/8/2022: Forbes Magazine asks “What do ALS and War Have in Common?” and highlights a refugee assistance program called Cash for Refugees developed by Mass General Neurology intern Natasha Dukach.
- Long Covid Symptoms May be Linked to Nerve Damage, a Small Study Suggests
3/3/2022: NBC News covers preliminary research into neuropathy related to COVID-19 infection by Mass General Neurologist Anne Louise Oaklander, MD, PhD. The research was also covered by more than 100 other publications, including the Deseret News, Becker's Hospital Review, the CBC (Canada), and HealthDay.
- Patient Dosing Begins in SLS-005 Arm of HEALEY ALS Platform Trial
3/2/2022: The fifth arm of the HEALEY ALS Platform Trial began delivering the investigational product SLS-005 (Trehalose) to patients this week.
- The Big Pain of Small-fiber Neuropathy
3/1/2022: Harvard Health speaks with Khosro Farhad, MD about the small-fiber neuropathy, a painful and often misunderstood condition.
- Rhode Island Man Living with Brain Mold Shares Story
2/28/2022: WHAR Channel 10 profiles a Rhode Island man with a rare fungal infection of the brain and speaks with his neurologist, James Hillis, MBBS, DPhil.
- Young Vermonter Makes Remarkable Recovery from Meningitis
2/21/2022: WCAX Channel 3 highlights patient care from Kristi Emerson, RN at Mass General's Neuro Recovery Clinic.
- Discussing Novel Imaging Outcomes in Multiple Sclerosis: Eric Klawiter, MD, MSc
2/17/2022: The director of the Multiple Sclerosis and Neuromyelitis Optica Unit at Massachusetts General Hospital outlined a presentation he gave at a recent Institutional Perspectives in Neurology: MS event.
- The End of Alzheimer's
2/16/2022: WebMD speaks with Rudy Tanzi, PhD in an article about new and forthcoming treatments for dementia.
- London-based CERF Prizes Benefit U.S.-based Research
2/11/2022: ALS News Today covers the award of the CERF Medical Engineering Prize to scientists at Brown University, Harvard University, and Mass General who are creating “soft robotics” to improve arm and hand function in people with ALS.
- Traumatic Brain Injury Warning Signs after Comedian Bob Saget’s Death
2/10/2022: Neurosciences Intensive Care Unit Director Eric Rosenthal, MD spoke with Boston 25 News about the importance of emergency treatment for head injuries, especially if symptoms include loss of consciousness, confusion, headache, nausea or vomiting.
- The Latest on the Civil Rights Trial of 3 Officers Involved in George Floyd's Death
2/9/2022: NPR spoke with Clinical Fellow Joshua Budhu, MD about how a diagnosis of "excited delirium" is used "to explain away any death in police custody."
- Loneliness May Triple Dementia Risk
2/9/2022: MedPage Today covers a study on dementia risk factors funded by the McCance Center for Brain Health at Mass General.
- Here’s How Running and Exercise Can Help Manage Multiple Sclerosis
2/4/2022: Runner's World spoke with Eric Klawiter, MD, MSc and Marcelo Matiello, MD about exercise and multiple sclerosis, and profiled an athlete living – and running the Boston Marathon – with the disease.
- It's Not Just You -- We Are All More Forgetful During the Pandemic, Experts Say. Here's How to Fix It
2/3/2022: Rudy Tanzi, PhD spoke with CNN about lifestyle changes that can improve memory and mental function, even during a disorienting pandemic.
- Therapieansatz gegen Demenz: Hormon Irisin ahmt Wirkung von Sport nach
2/1/2022: German public radio station Deutschlandfunk covers research by Christiane Wrann, DVM, PhD into the effect of the "exercise hormone" irisin on cognitive function. (Broadcast in German)
- How a Hyperactive Cell in the Brain Might Trigger Alzheimer's Disease
1/30/2022: NPR features work by Rudy Tanzi, PhD, on recent breakthroughs in the understanding of how neurinflammation may trigger Alzheimer's Disease.
- Duluth-based Essentia Health, state Sen. David Tomassoni join national ALS trial
1/27/2022: The Minneapolis Star-Tribune covers the newest HEALEY ALS Platform Trial location, and the fact that state Senator David Tomassoni is taking part. Significant funding for the new trial location comes from local ALS advocacy Group Never Surrender, which is conducting a three-day snowmobile tour this weekend. The senator's participation at the new trial location and the funding event were also covered by NBC affiliate KBJR and ABC affiliate WDIO.
- Exploring Why Some Remain Sharp Even as Decades Roll By
1/21/2022: The Harvard Gazette interviews Assistant Professor of Neurology Alexandra Touroutoglou, PhD, about her work studying the brains of those who avoid cognitive decline as they age.
- Sports Talent Booker John Carlin's Passion Sparked Positivity, ALS Awareness
1/14/2022: A tribute to the late sports talent booker, producer and ALS activist John Carlin, featuring Merit Cudkowicz, MD, MSc as well as Magic Johnson, Metta World Peace and Roy Firestone.
- Shield your brain from decline
2/1/2022: The SHIELD acronym, developed by neuroscientist Rudolph Tanzi, co-director of the McCance Center for Brain Health, helps people with lifestyle habits that help protect memory and thinking skills.
- Sleep Brain Wave Patterns May Help Physicians Diagnose Dementia, Other Cognitive Issues
1/14/2022: A new study from the McCance Center for Brain Health shows that "sleep spindle" brain wave patterns may help improve automated methods for detecting these spindles and correlating them with brain function.
- Pridopidine Arm of HEALEY ALS Platform Trial Fully Enrolled
1/10/2022: A fourth arm of the HEALEY ALS Platform Trial is now fully enrolled, moving the trial one step closer to delivering results about another experimental ALS treatment.
- Olfactory Receptor Gene May Play Role in Spread of Breast Cancer
1/4/2022: New collaborative research between oncologists and neurologists has found that an olfactory gene may figure prominently in cancer progression, and could be targeted as a way of preventing metastasis. Health IT Analytics also covered the project. Learn more.
- PRO-ACT Database Wins Healey Center Prize for Innovation in ALS
12/28/2021: ALS News Today covers the Healey Prize for Innovation in ALS, awarded to the PRO-ACT database, which pools research data to accelerate research.
- Front Row: Breakthroughs in Alzheimer’s: Genetics, Biomarkers and Gene Therapy
12/15/2021: Genetic Engineering & Biotechnology News covers promising research featuring Rudy Tanzi, PhD
- How I Use Segmented Sleep to Live with Insomnia
12/13/2021: An insomniac journalist consults Mass General Investigator Elizabeth Klerman, MD, PhD and other experts about sleep patterns and learns that although "you can eat when you're not hungry, there is no evidence that you could oversleep."
- On the hunt for new ALS drugs, researchers see progress, and a long road ahead
12/13/2021: BioPharma Dive spoke with Chief of Neurology Merit Cudkowicz, MD, MSc during their coverage of advances, setbacks and promising new research on ALS.
- BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's Phase 3 Study for ALS in Muscle and Nerve
12/13/2021: BioSpace quotes Merit Cudkowicz, MD, MSc in coverage of the release of the latest study results of Phase 3 clinical trials for a potential new ALS therapy.
- Timing is everything — old saying could also be true for COVID-19 vaccine shots
12/10/2021: CBS 17 covers research from Elizabeth Klerman, MD showing that circadian rhythm may improve the effectiveness of vaccinations delivered in the afternoon. The study was also covered by DNA.fr, the Harvard Gazette, HealthDay News, the San Jose Mercury-News, and the San Francisco Chronicle.
- Most patients with COVID-19-linked disorders of consciousness recover
12/09/2021: Healio covers a Mass General study of the long-term effects of unconsciousness during severe COVID-19 infection.
- Changes in a small area in the brainstem could help detect Alzheimer’s disease earlier
12/09/2021: NIH News features research from Mass General on new advancements in brain imaging that may help diagnose Alzheimer’s, even before cognitive deficits emerge.
- Tau Protein in Alzheimer’s Linked to ALS Mitochondrial Dysfunction
11/23/2021: An abnormal version of tau, a protein associated with Alzheimer’s disease, may contribute to the progression of amyotrophic lateral sclerosis (ALS) by damaging mitochondria in neurons, according to a new study from Mass General Investigator Gahaleh Sadri-Vakili, PhD.
- HEALEY Trial Fully Enrolled for 2 Regimens; Data Expected by Mid-2022
11/16/2021: Enrollment is now complete for three of the HEALEY ALS Platform Trial's first five treatment arms, a major milestone that means results may be available in just a few months.
- Mini-brain Model of Frontotemporal Dementia Demonstrates the Stages of Dysfunction that Lead to Cell Death
11/4/2021: The NIH features new research on frontotemporal dementia co-authored by Mass General Investigator Maria Catarina Silva, PhD and researchers at several other institutions.
- Researchers Boost Human Mental Function with Brain Stimulation
11/1/2021: A collaboration between the University of Minnesota and researchers at Mass General and McLean Hospital demonstrated improvement in specific human brain functions related to self-control and mental flexibility by merging artificial intelligence with targeted electrical brain stimulation. The study was also covered in Futurism magazine.
- Life After Brain Injury
10/14/2021: Carolyn Gold contracted West Nile Encephalitis and spent more than a week in a coma; after she recovered, she wrote a memoir and guide to recovery for brain injury patients, with contributions from her neurologist, James Hillis, MBBS, PhD.
- MJFF Details Need for Diversity in Parkinson’s Research, Care
10/13/2021: Parkinson's News Today highlights work by Mass General Neuroscientist Jonathan Jackson, PhD to recruit more diverse research participants to help find effective treatments for neurological disease.
- Protective, Risk-Linked APOE Alleles Affect Glial Cell Transcriptome
10/11/2021: GenomeWeb covers the latest research from Sudeshna Das, PhD and Alberto Serrano-Pozo, MD, PhD on genetic markers of susceptibility and resistance to dementia.
- ¿Cuál es la enfermedad que alejó a ‘Mandíbula’ de Sábados Felices?
10/6/2021: Following an Alzheimer's diagnosis for one of the country's most beloved comedians, Teresa Gómez-Isla, MD, spoke with Colombian newspaper El Tiempo about dementia prevention and treatment.
- Superfoods to Help You Sleep
10/5/2021: AARP spoke with Mass General Sleep Physician Josna Adusumili, MD and several nutritionists about what and when to eat to help you get a restful night's sleep.
- Telestroke Implementation Did Not Change Systems of Care in Hospitals
10/4/2021: Healio reports on research from the Departments of Neurology and Emergency Medicine, suggesting that more work can be done to maximize the benefits of telemedicine for stroke care.
- Early Access to CNM-Au8 Given to Patients Ineligible for HEALEY Trial
9/28/2021: ALS News Today covers efforts to enroll additional people with ALS in expanded access programs for an experimental ALS treatment, even when they do not qualify for participation in a clinical trial.
- World Alzheimer's Day Provides Opportunity to Raise Awareness
9/21/2021: Rudy Tanzi, PhD spoke with ABC News affiliate WCVB about World Alzheimer's Day and ways people can keep their brains healthy as they age.
- Stuck in a Brain Fog? Look in Your Medicine Cabinet
October, 2021: Harvard Health Publishing speaks with Mark Albers, MD, PhD about how some medications — both prescription and over-the-counter — can cause memory problems.
- Patients and Doctors Who Embraced TeleHealth During the Pandemic Fear it Will Become Harder to Access
9/15/2021: The Washington Post spoke with Mass General Vascular Neurologist Anand Viswanathan, MD, PhD as well as patients and clinicians who have come to rely on telehealth during the pandemic, and who are concerned that it will no longer be available to them in the future.
- Long-haul COVID-19 Can Last Months. But Here’s Why Experts are Optimistic About Recovery
9/17/2021: USA Today (subscription required) quotes Mass General Neurologist Zeina Chemali, MD, MPH, who is part of the McCance Center for Brain Health COVID-19 Survivors Clinic.
- Dosing Begins in Phase 2 Trial of AL001 in ALS With C9orf72 Mutations
9/13/2021: ALS News Today spoke with Principal Investigator Katie Nicholson, MD and industry partners as they launched a clinical trial of a promising new ALS treatment.
- Amylyx Pharmaceuticals Donates CENTAUR Clinical Trial Data and Participant Samples
9/13/2021: Coverage of a major donation to the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database, which is managed by Alex Sherman, MS at the Healey Center and Mass General Neurological Clinical Research Institute (NCRI).
- Health Care Today: Headaches (Podcast)
9/10/2021: WDEV Radio's Dr. Louis Meyers spoke with Hsinlin Thomas Cheng, MD, PhD, the Director of the MGH Headache and Neuropathic Pain Unit, about headache severity and treatments.
- Analysis Weighs Use of Prophylaxis Antiseizure Drugs in Aftermath of Spontaneous Intracerebral Hemorrhage
9/2/2021: Neurology Today discusses a new study from Lidia Moura, MD, PhD, MPH of the NeuroValue lab, which suggests that a conservative approach to post-stroke seizure prevention could both reduce costs and improve outcomes.
- How Exercise May Help Keep Our Memory Sharp
8/25/2021: The New York Times covered a study led by Christiane Wrann, DVM, PhD and Se Hoon Choi, PhD that may illuminate the mechanism that connects exercise and cognitive health. The study was also covered by Psychology Today, Mental Daily, Harvard Medical School News, News@Northeastern, the NIH National Institute on Aging Featured Research Blog and the Economic Times (India).
- Having a Good Listener Improves Your Brain Health
8/16/2021: A new study, the result of a collaboration between numerous research centers including the McCance Center for Brain Health, reveals the ways in which positive social interactions build brain health and resilience.
- A Game-Changing Trial Offers New Hope for ALS
8/13/2021: Medscape interviews Sabrina Paganoni, MD, PhD about promising developments in the CENTAUR trial for ALS.
- Meet the Retirees With the Memory of a 25-year Old
8/7/2021: MarketWatch reports on advances in aging research at Mass General, where investigators have identified key regions of the brain associated with well-preserved cognitive function
- Former Competitive Swimmer Races Against the Clock for a Cure for ALS
7/2/2021: WTVQ profiles Sandra Marlowe, an award-winning swimmer now facing down a new opponent: ALS. Sandra is also a participant in the HEALEY ALS Platform Trial, and hopes that her experience can help others
- Convert Mental Handwriting Into On-screen Text
8/2/2021: Illinois News Today covers research into brain-computer interfaces by Leigh Hochberg, MD, PhD and collaborators in the BrainGate consortium
- Short-term Seizure Prophylaxis Provides Greatest Benefit after Intracerebral Hemorrhage
8/2/2021: Lidia Moura, MD, MPH, along with Research Fellow Felipe J. S. Jones, MD and other collaborators, has proposed an optimal course of anti-seizure treatment for patients following an ICH, reports Healio. The work was also covered by Medscape
- Why Strokes Can Affect Women, Men Differently
7/29/2021: US News & World Report and HealthDay coverage of a study on sex differences in stroke outcomes co-authored by Mass General Stroke Division Chief Natalia Rost, MD
- Nerve Damage in Cornea Could Be Sign of 'Long COVID,' Study Hints
7/26/2021: Live Science spoke with Anne Louise Oaklander, MD, PhD about a Qatar hospital's new study of nerve damage caused by COVID-19
- Surviving Locked-in Syndrome: How One Man Confounded Expectations of Death
7/25/2021: CBS News profiled physician Brian Edlow, MD, and a patient who recovered from a rare and devastating type of brain injury
- The Mysterious, Remarkable Memories of ‘Superagers’
7/23/2021: Coverage of research by Alexandra Touroutoglou, PhD, into ways that some people resist age-related cognitive decline
- Mass General Brigham Unlikely to Recommend Alzheimer’s Drug to Patients on Blood Thinners
7/15/2021: The Boston Globe quotes Teresa Gomez-Isla, MD on the risks the controversial new drug could pose to people taking anticoagulant medication
- Tapping Into the Brain to Help a Paralyzed Man Speak
7/14/2021: The New York Times quotes Leigh Hochberg, MD, PhD in coverage of a neuroprosthetic that has restored a paralyzed man's ability to speak, and also links to an editorial about it that he and Sydney Cash, MD, PhD wrote for the New England Journal of Medicine. The experiment and editorial have also been covered by US News & World Report and the San Jose Mercury News
- Researchers Identify Signaling Molecule That May Help Prevent Alzheimer’s
7/14/2021: Harvard Gazette highlights new work by Rudy Tanzi, PhD and collaborators on the connection between interleukin-3 and neurodegeneration
- Dying Patients With Rare Diseases Struggle to Get Experimental Therapies
7/14/2021: Kaiser Health News highlights the Healey Center's expanded access program in its coverage of the struggle to access experimental drugs to treat rare and terminal diseases
- Mass Spectrometry: An Important Tool to Unravel Mechanisms Underlying Huntington's Disease
7/14/2021: Coverage of new research on advanced Huntington's disease research techniques that could accelerate the search for a cure
- Highly Respected, Beloved Pediatric Neurologist Dies
7/9/2021: Several members of the Mass General Neurology community, including Natalia Rost, MD and Melissa Walker, MD, PhD, shared tributes to the late Professor of Neurology Emeritus Verne Caviness, MD in this Medscape remembeance of his outstanding career
- Alzheimer's Biomarkers Tied to Endogenous Estrogen Exposure in Women
7/8/2021: Rachel Buckley, PhD was quoted in a MedPage Today article about new research on sex differences in Alzheimer's disease
- FDA Narrows Recommended Use of Biogen Alzheimer’s Therapy After Flood of Criticism
7/8/2021: Teresa Gomez-Isla, MD was quoted in the Boston Globe in an article about the promise and risks of the controversial new drug Aducanumab
- Superager Study Uncovers How Aging Brains Maintain Superior Memory
7/6/2021: New Atlas coverage of a study co-authored by Mass General investigators Alexandra Touroutoglou, PhD and Yuta Katsumi, PhD into how "superagers" maintain strong cognitive function into their later years. The research was also covered in Technology Networks and IFL Science
- Doctors Warn Against Off-label Use of Aducanumab Amid Adverse Amyloid Imaging Findings
7/6/2021: Steven Greenberg, MD, PhD is among physicians warning that a controversial new Alzheimer's drug presents additional risks if used off-label for diseases like central amyloid angiopathy; his warning was also covered by Healio
Official Lou Gehrig NFT Auction to Benefit ALS Charities
7/4/2021: Major League Baseball and digital collectible company Candy Digital unveiled baseball's first officially licensed NFT, commemorating Lou Gehrig’s “Luckiest Man” speech. Proceeds from the auction will benefit ALS charities including the Healey Center
- Two Inflammatory Proteins Linked With Slower Cognitive Decline
6/23/2021: In a surprising finding, Rudy Tanzi, PhD and collaborators report that elevated levels of two inflammatory proteins were associated with slower cognitive decline in older adults. The research was also covered in Genetic Engineering & Biotechnology News and the French website Santé Log
- What to Know About Alzheimer's Disease
6/17/2021: Rudy Tanzi, PhD contributed to an AARP article on about the early symptoms, warning signs and stages of Alzheimer's disease, and what the latest drug news means
- BrainGate Consortium Develops New Approach of Brain-to-text Communication Through Handwriting
6/16/2021: Additional coverage of progress in brain computer interfaces led by Leigh Hochberg, MD, PhD and the Braingate research group
- Drinking More of This Can Slash Your Parkinson's Risk, Study Says
6/11/2021: Best Life covers research by Grace Crotty, MD, BAO, MBBCH on the connection between caffeine intake and lowered risk of Parkinson's disease
- Genetics of Dementia
June 2021: Practical Neurology interviewed Rudy Tanzi, PhD, on how “genetic discovery informs our understanding of disease mechanisms and potential drug targets”
- AAN: Ban Chokeholds, Strangleholds in Law Enforcement
6/10/2021: The American Academy of Neurology formally endorses public safety policy recommendations developed by Altaf Saadi, MD, MSc and collaborators, recommending a ban on these techniques by police forces
- Lucy Frates, Daughter of Pete Frates, Throws Out First Pitch at Fenway Park Before Red Sox Game
6/8/2021: The Red Sox honored the family of ALS champion Pete Frates and the Healey Center for ALS in a special pre-game celebration
- Local Alzheimer's Patients And Families Hail New Biogen Drug As Landmark
6/8/2021: WGBH spoke with Rudy Tanzi, PhD and other experts and patient advocates about the new drug Aducanumab and its potential to spur further developments in Alzheimer's treatment. Separately, Dr. Tanzi spoke about the drug in a video confrence with Maria Shriver
- Aeterna Zentaris Engages Dr. Michael Levy to Support Development of Autoimmune and Inflammatory CNS Disorders Programs
6/7/2021: Yahoo Finance covers the announcement that Michael Levy, MD, PhD will be working with specialty pharmaceutical company Aeterna Zentaris on the development of new drugs to treat Neuromyelitis Optica and related disorders
- Early Alzheimer's Trajectories May Vary Widely
6/4/2021: It's hard to predict the course of Alzheimer's Disease, and that can make it hard to tell if a potential new therapy is effective, writes MedPage Today, covering an editorial by Rachel Buckley, PhD and collaborators
- Long-term Cardiac Monitoring Detects Unsuspected AFib Among Stroke Patients
6/2/2021: Cardiovascular Business continues coverage of research from Lee Schwamm, MD that could improve outcomes for people recovering from stroke
- A Conversation Around ALS – Lou Gehrig Day
6/2/2021: Oakland A’s Outfielder Stephen Piscotty and ESPN broadcaster Jon “Boog” Sciambi talk about ALS and Lou Gehrig Day with Healey Center Director Merit Cudkowicz, MD, MSc
- As M.L.B. Honors Lou Gehrig, It Shines a Spotlight on A.L.S.
6/1/2021: The New York Times spoke with Merit Cudkowicz, MD, MSc and patient advocate Gwen Petersen about Major League Baseball's fundraising and awareness efforts surrounding Lou Gehrig Day
- Harvard Researchers and Clinicians Battle 'Silent Pandemic' of Mental Health Issues
5/27/2021: The Crimson profiles the efforts of Zeina Chemali, MD, MPH, and other psychiatrists and neurologists to address the mental health impacts of the COVID-19 pandemic
- Get Well With Dr. Shel – Advances in ALS Treatment
5/26/2021: As part of ALS Awareness Month, Merit Cudkowicz, MD, MSc appeared as a special guest on the Get Well With Dr. Shel podcast to discuss recent developments in ALS care and research
- Why Dementia Can Be Different for Latinos
5/25/2021: AARP.org covers research from Mass General and the Harvard Aging Brain Study, among others, that attempts to address disparities in Alzheimer's diagnosis and treatment
- Everything You Need to Know About Telehealth If You Suffer from Depression
5/25/2021: Parade Magazine spoke with Lee Schwamm, MD and other experts about the benefits and drawbacks of telehealth
- MedRhythms Launches Trial of Rhythmic Sound Therapy to Aid Walking
5/21/2021: Multiple Sclerosis News Today News Today writes about a trial co-led by Eric Klawiter, MD, to determine if pulsed rhythmic or musical stimulation can improve walking ability in patients with MS
- Frontotemporal Dementia at 29: A LiveTalk With Dawn Kirby and Dr. Brad Dickerson
5/20/2021: Brad Dickerson, MD speaks with a patient's mother about the diagnosis, treatment and care of people living with this devastating neurological disorder
- Patent Foramen Ovale Shunting for Stroke Raises Circulatory Biomarker Levels
5/19/2021: Neurology Today covers new research on optimizing treatment for Patent Foramen Ovale (PFO) by Wenjun Deng, PhD
- Answering the Call: The Healey ALS Platform Trial
5/17/2021: BioSpace highlights some of the patients and experimental study drugs involved in the HEALEY ALS Platform Trial
- High-performance Brain-to-text Communication via Handwriting
5/12/2021: The cover article in Nature highlights a mechanism developed by Leigh Hochberg, MD, PhD and the BrainGate research group that allows a patient with tetraplegia to write again. The work has also been covered by NPR, c|net, and more
- Keep Your Brain Healthy at Every Age
5/12/2021: Rudy Tanzi, PhD is quoted in this articule about key ways to preserve brain health, and how to tell the difference between normal forgetfulness and warning signs of cognitive decline
- Researchers Make Breakthrough in Brain-Computer Interface Technology
5/10/2021: Leigh Hochberg, MD, PhD and the BrainGate research group have demonstrated the first use of a wireless brain-computer interface, transmitting brain signals at single-neuron resolution
- Advocacy, Fundraising Events Mark ALS Awareness Month
5/4/2021: ALS News Today highlights ALS fundraising and advocacy events, including a live webinar with Sabrina Paganoni, MD, PhD
- Cerebral Small Vessel Disease Implicated in Greater ICH Recurrence Risk Among Minorities
5/3/2021: Healio covers the work of Juan Pablo Castello, MD to understand and address stroke care disparities for people of color
- People With Neurological Conditions At Greater Risk of Death by COVID-19
4/29/2021: U.S. News spoke with Mass General Stroke Division Chief Natalia Rost, MD about a new study showing greater COVID-19 risks for people who have pre-existing neurological conditions
- Tyler Decker, Working to #WipeOutALS
April 2021: Carlsbad Magazine covers local surfer Tyler Decker, diagnosed with ALS at just 26 years old, and his efforts to raise money for research and treatment
- An Experimental Gene Therapy Was Little Alissa's Only Hope
4/25/2021: USA Today spoke with Florian Eichler, MD while profiling a patient with a rare genetic disorder and the research breakthroughs that make her treatments possible
- How 'Bleeding' Stroke Affects Brain May Depend on Your Race
4/22/2021: Health Day covers research by Alessandro Biffi, MD on racial disparities in health outcomes after hemorrhagic stroke. A separate article highlighted the research contributions of Juan Pablo Castello, MD
- HIV Patients Show Accelerated Aging Related to Altered Sleep
4/20/2021: Medscape covers work by Shibani Mukerji, MD, PhD and Brandon Westover, MD, PhD on the interactions between HIV, sleep patterns, and brain health
- Advocacy, Fundraising Events Mark ALS Awareness Month
5/3/2021: Healio covers the work of Juan Pablo Castello, MD to understand and address stroke care disparities for people of color
- A Mentoring Program Is a Draw for Underrepresented Students
4/19/2021: Neurology Today covers the ways that outreach and mentorship programs developed by Nicte Mejia, MD, MPH, FAAN are encouring young people of color to pursue careers in neuroscience
- Novel ALS Drug Continues to Show Survival Benefit
4/19/2021: Updated research presented at the American Academy of Neurology Annual Meeting shows ongoing benefits of the experimental drug AMX0035 for both function and survival in ALS patients
- Common MS Treatment Wears Off More Quickly in Black Patients
4/17/2021: MedScape spoke with Eric Klawiter, MD about new research that could reduce health care disparities for people suffering from Multiple Sclerosis and related disorders
- Global Stroke Care Takes a Hit During the Pandemic
4/17/2021: MedPage Today spoke with AAN Science Committee chair Natalia Rost, MD about a new study of global stroke care during the COVI-19 pandemic
- Five-Minute Digital Clock Test May Speed Early Alzheimer's Diagnosis
4/16/2021: Dorene Rentz, PsyD and her collaborators at the Harvard Aging Brain Study are developing a faster and more accurate way to detect the earliest signs of cognitive impairment, enabling patients to be treated sooner
- Use of Comfort Care Increasing After Stroke, May Reduce Costs
4/14/2021: Steven Greenberg, MD, is quoted in an article about changes and disparities in how doctors care for patients with severe stroke
- Terrifying Viral Videos of Shaking After COVID-19 Vaccines Are Not What They Seem
4/12/2021: David Perez, MD, who authored a recent paper on medical communication surrounding vaccines, helps allay fears caused by several viral videos purporting to show vaccine side effects
- Insertable Cardiac Monitor Improves Detection of AF in Recent Ischemic Stroke
4/12/2021: Ongoing coverage of work by Lee Schwamm, MD on improvements in post-stroke patient monitoring that can help prevent repeat strokes
- Mass General Team Uncovers 13 New Alzheimer's Gene Variants
4/2/2021: Investigators led by Rudy Tanzi, PhD have identified 13 additional gene variants that are associated with Alzheimer's Disease, a discovery which could lead to new or more effective treatments. The research was also covered in The Hill/Changing America, Health IT Analytics and Genetic Engineering & Biotechnology News
- ALS Groups Give $1.1M More in Support of T-cell Therapy in Phase 2 Trial
4/1/2021: ALS News Today covers new funding for a clinical trial of regulatory T-cells, or Tregs, led by investigators at Mass General and Houston Methodist Neurological Institute
- Some Hospitalized COVID Patients Develop Seizures
4/1/2021: M. Brandon Westover, MD, PhD spoke with HealthDay about his new research on non-convulsive seizures in COVID-19 patients. The work was also covered in The Scientist and the infectious diseases journal Contagion
- Talking To Patients And Their Families, Even When There's Nothing To Say
3/31/2021: Neurology resident Michael P. H. Stanley, MD, writes about his gratitude for the ways in which he's learned to be a better doctor from patients and their families
- ALS Patients Fight for the Right to Try Patient-Centric Trial Design
3/30/2021: BioSpace spoke with Healey Center Director Merit Cudkowicz, MD, MSc about the importance and scientific value of expanded access to experimental drugs, even outside of clinical trials
- 2021 Clinical Research Forum: The CENTAUR Trial for ALS
3/24/2021: Sabrina Paganoni, MD, PhD explains the exciting results from the CENTAUR trial for ALS, a finalist in the Top 10 Clinical Research Awards from the Clinical Research Forum
- AMX0035 Lowers Risk for Adverse Events, Death in Patients with ALS
3/22/2021: Healio covers ongoing results from the CENTAUR trial and its extension study, which are providing a growing pool of evidence that the experiemental ALS treatment may be safe and effective. Dr. Paganoni's presentation of the data at the annual MDA conference was also covered in ALS News Today
- A Fatal Five Minutes: Prosecutor questions 'excited delirium' in Richland jail death
3/18/2021: Altaf Saadi, MD, MSc, helps explain why experts—including an Ohio special prosecutor—are increasingly skeptical about the use of "excited delirium" as an explanation for deaths in police custody
- Loop Recorder Proves Mettle in Broader Stroke Population
3/18/2021: Lee Schwamm, MD, presented results from a clincial trial of post-stroke monitoring for atrial fibrillation; their work could help doctors reduce the risk of repeat strokes. The study was also covered in Medscape
- AI Helps ID Alzheimer's Treatments
3/12/2021: AI could help apply current drugs to Alzheimer's disease, as well as find new treatment targets, according to research from Steve Rodriguez, PhD, Mark Albers, MD, PhD and their collaborators. That could dramatically accelerate the search for cures. This research was also covered by Science Daily, the Times of India, and dozens of other outlets
- HMS Researchers Use Machine Learning to Recommend Drugs for Alzheimer’s Disease Clinical Trials
3/12/2021: The Crimson covers research by collaborators including Mark Albers, MD, PhD, on the uses of machine learning to identify possible Alzheimer's disease drugs
- Amylyx Planning to Ask Health Canada to Approve AMX0035 to Treat ALS
3/11/2021: Sabrina Paganoni, MD, PhD, who led a clinical trial of the experimental ALS drug AMX0035, is quoted in this article about possible approval by Canadian regulators
- Grafton Dad Runs 48 Miles to Raise Awareness for Son's Rare Disease
3/9/2021: Chris Marino ran an incredible 48 miles in 48 hours in an effort to raise awareness and research funding for adrenoleukodystrophy (ALD)
- How to Prep Your Body for Turning the Clocks Ahead for Daylight Saving Time
3/8/2021: Everyday Health spoke with Mass General Sleep Researcher Elizabeth Klerman, MD, PhD, about how to prepare for time adjustments
- The Transformational Impact of COVID-19 on Medical Education
3/8/2021: Neurology Fellows Patrick Chen, MD and Fábio Nascimento, MD spoke about the disruptions to medical education and service caused by the COVID-19 pandemic
- Maine Boy Was Suffering Nearly 200 Seizures a Day. Now He's Gone 27 Days Without One
3/5/2021: Ten-year-old Wyatt Beauchamp was suffering from terrifying seizures caused by Doose Syndrome, but treatment at Mass General has helped to alleviate them
- Could Taking a Swing at Golf Help Parkinson's Patients?
3/3/2021: Research from Anne-Marie Wills, MD, MPH, suggests while all forms of exercise are helpful at alleviating symptoms of Parkinson's disease, golf may be especially good. One possible reason: patients enjoy it and are more likely to do it consistently. The research was also covered in La Razón (Madrid) and Medscape
- A New ALS Drug is Extending Patients' Lives by Months
3/2/2021: USA Today covers efforts to fast-track approval for the experimental ALS drug AMX0035 and ongoing research at the Healey Center for ALS
- Telemedicine for Stroke Improves Patient Outcomes, Saves Lives
3/2/2021: Harvard Medical School reports on research by Lee Schwamm, MD and others providing the first national analysis of telestroke patient outcomes and clearly demonstrating its lifesaving advantages
- Altaf Saadi, MD, MSc, Honored with Sylvia Ferrell-Jones Award
2/25/2021: YW Boston has selected Altaf Saadi, MD, MSc for the Syvia Ferrell-Jones Award, given annually to an up-and-coming young professional woman of color who is a leader in her field
- Can AI Machine Learning and Genomics Find Alzheimer’s Drugs?
2/24/2021: Mark Albers, MD, PhD and other Mass General researchers have developed a framework that may allow machine learning to identify existing drugs that could be repurposed to treat Alzheimer's disease, potentially accelerating the search for better treatments
- When Does COVID-19 Become A Disability? 'Long-Haulers' Push For Answers, and Benefits
2/22/2021: NPR covers the ongoing struggles of people with long-term COVID-19 symptoms, and the work of Mass General Neurologist Zeina Chemali, MD, MPH, who runs a clinic focused on their condition
- Clinical Trials Are Moving Out of the Lab and Into People’s Homes
2/18/2021: The New York Times profiles clinical trials that have reduced in-person visits during the COVID-19 pandemic, including a study by Steven Arnold, MD which has moved to an entirely virtual format
- Novel Approach Measures Tau Changes That Correlate With Dementia Stage
2/18/2021: BioIT World covers research at Mass General and Boston Children's Hospital that uses mass spectrometry to expand understanding of tau proteins in the brain
- ALS Warrior Fights On for Herself and Those that Will Follow
2/15/2021: WKYC profiles ALS patient and Healey Center research trial participant Susie VanVranken
- Falmouth Couple Fundraise for a Cure of Neurological Disease
2/14/2021: Since 2002, Peter and Andrea Cahill of Falmouth, MA have raised more than $200,000 to support Mass General's research on neurofibromatosis type 2
- COVID-19 Pandemic Fuels Rise in Alzheimer’s Deaths
2/9/2021: Everyday Health spoke with Marie Pasinski, MD, about increased risks for Alzheimer's patients during the COVID-19 pandemic
- As Telehealth Appointment Numbers Boom, Doctors Weigh the Pros and Cons
2/6/2021: Boston University News spoke with Lee Schwamm, MD about the benefits and disadvantages of telemedicine
- ‘Web-side’ Techniques to Improve the Neurology Telemedicine Exam
2/4/2021: Neurology Today covers best practices in teleneurology and telehealth with Lee Schwamm, MD
- Mass General Brigham Expands Virtual Care to Free up Vaccination Space
1/28/2021: Boston Business Journal spoke with Lee Schwamm, MD about the use of virtual appointments as a way to allocate more space to in-person vaccinations
- Some COVID Longhaulers Working on Hospital Frontlines Struggle With Lingering Symptoms
1/27/2021: WGBH covers the work of Zeina Chemali, MD, MPH with COVID-19 "long-haulers," suffering from long-term neurological complications after COVID-19 infection
- Exercise Rehab Should Include Stroke Survivors, Study Suggests
1/27/2021: Lee Schwamm, MD, spoke with HealthDay about the importance of cardiovascular exercise for people recovering from stroke, even if they do not have a specific disability
- Mass General To Conduct Research on How Psychedelics Affect the Brain
1/27/2021: The Boston Globe discusses a new research project on this once-controversial topic co-led by Jerrold Rosenbaum, MD of the Department of Psychiatry and Stephen Haggarty, PhD, of the Department of Neurology, in partnership with Atai Life Sciences
- In Acute Ischemic Stroke, Women Present With Greater Severity than Men
1/26/2021: Healio covers new research on sex differences in stroke presentation, treatment and outcomes
- Patients Paying More for Neurologic Care, Study Finds
1/21/2021: Neurology Today spoke with Lidia Moura, MD, MPH about new research on the cost of neurological care and the dangers rising costs could pose
- COVID-19’s Effects on the Brain
1/20/2021: The Scientist magazine spoke with Shibani Mukerji, MD, PhD and other experts about current research on the neurological consequences of COVID-19 infection
- As COVID-19 Accelerates Digital Health Innovation, 'Who Will We Leave Behind?'
1/15/2021: Lee Schwamm, MD speaks with Devex about the need to ensure that the benefits of telehealth get distributed more widely and equitably
- NeuroVoices: Fabio Nascimento, MD, on Improving EEG Education in Residency Programs
1/13/2021: Neurology Live interviewed Fabio Nascimento, MD, a clinical fellow at Mass General, about his research into neurology resident EEG education and how it can be improved
- Can COVID Long-Haulers Access Disability Benefits? Experts Are Uncertain
1/13/2021: WGBH speaks with Zeina N. Chemali, MD, MPH, about care and support for patients with post-COVID neurological symptoms
- CES 2021: What Is the Post-Pandemic Future for Telehealth and Digital Health Technology?
1/13/2021: Lee Schwamm, MD was among the experts discussing the future of telemedicine on a panel at the all-virtual 2021 Consumer Electronics Show (CES)
- Hospitals Must Help Their Own COVID Long-haulers Recover, Experts Argue
1/12/2021: Eurekalert discusses an article in The Lancet Respiratory Medicine by several Mass General researchers, which highlights the difficulties facing health care providers with long-term post-COVID symptoms. Zeina N. Chemali, MD, MPH, is running a clinic focused on these patients
- COVID-19 Safety Measures Announced for Biomarker Study
1/11/2021: ALS News Today covers the use of telemedicine and other protocol changes to enhance the safety of research study participants during COVID-19
- The Research and Work of NAM Inductee Merit Cudkowicz
1/5/2021: The Neurology.org podcast interviews Healey Center Director Merit Cudkowicz, MD, MSc about her career, recent breakthroughs and her induction into the National Academy of Medicine
- Awareness of Memory Decline Decreases in Predementia Stages Among AD Variant Carriers
12/31/2020: Healio covers new research from Patrizia Vannini, PhD, into the level of insight patients have into their own mental function as it begins to decline
- No Medical Justification For Police Chokeholds, Neurologists Say
12/28/2020: All Things Considered interviewed Altaf Saadi, MD, MSc, about the dangers of police chokeholds. Dr. Saadi is a co-author, along with two other Mass General Brigham doctors, of the recent JAMA Neurology article "Carotid Physiology and Neck Restraints in Law Enforcement: Why Neurologists Need to Make Their Voices Heard"
- Fearing for His Life, He Sought Safety in the U.S. He Ended Up in a Wheelchair
12/28/2020: The Fort Worth Star-Telegram covers the case of a refugee who suffered debilitating injuries while in jail for border violations. Altaf Saadi, MD, MSc, of the MGH Asylum Clinic, reviewed the records of his medical care
- Telemedicine Here To Stay In Massachusetts, Proponents Say
12/23/2020: WGBH speaks with Mass General Neurologist and Vice President for Virtual Care of Lee Schwamm, MD about the benefits of telehealth
- Target ALS Awards 4 Grants for Work Into Biomarker Discovery
12/21/2020: ALS News Today coverage of grants to support a collaboration between NeuroDex, Massachusetts General Hospital, and Johns Hopkins University that will investigate extracellular vesicles (EVs) as potential ALS biomarkers
- Cannabidiol Found to Reduce Drug-resistant Seizures in Tuberous Sclerosis Complex
12/21/2020: MDAlert covers a new publication in JAMA Neurology in which Elizabeth Thiele, MD, PhD demonstrates more evidence that CBD can be effective against treatment-resistant epilepsy
- COVID-19 Pandemic Creates New Roles for Advanced Practice Providers
12/17/2020: Mass General Advanced Practice Providers including APP Director and ALS Nurse Practitioner Darlene Sawicki, MSN, NP-BC write about how the APP team built their multidisciplinary COVID-19 response team in the first months of the pandemic
- “Fringe Theory”? The Link Between Viruses and Alzheimer’s Gains Traction
12/16/2020: Being Patient covers research by Rudy Tanzi, PhD and others on possible links among infections, neuroinflammation, and the production of amyloid in the brain
- In Life, She Defied Alzheimer’s. In Death, Her Brain May Show How
12/11/2020: Continuing New York Times coverage of a unique patient whose brain may hold clues to preventing Alzheimer's disease, and a long-running collaboration on familial Alzheimer's between University of Antioquia and Mass General researchers led by Yakeel Quiroz, PhD
- Frates Run Goes Virtual for 2020
12/10/2020: The Salem News covers the annual Frates Memorial 5k run to benefit the Healey Center, conducted virtually this year
- Recommendations To Reduce Disparities in Dementia Care Due in 2021
12/9/2020: McKnight's Senior Living speaks with Katie Brandt from the Mass General Frontotemporal Disorders Unit about forthcoming recommendations to reduce disparities and financial burdens in dementia care
- Don’t Place Too Many Restrictions on Telehealth
12/5/2020: Lee Schwamm, MD co-authors an editorial in Commonwealth Magazine about the importance of telehealth to care during and after the COVID-19 pandemic
- How Two College Kids Cooked Up a Two-Drug Combination for ALS
12/3/2020: The unlikely story of how two undergrads with a big idea got the attention of researchers at Mass General and developed the most promising ALS drug in years
- MOG Antibody Disease Differs for Children and Adults
12/3/2020: Neurology Today covers new research on MOG antibody disease from the Neuromyelitis Optica Clinic at Mass General
- Clinical Challenges: New Therapies in Neuromyelitis Optica
11/30/2020: MedPage Today speaks with Michael Levy, MD, PhD about three new approved therapies for NMO patients, who previously had few options to treat the rare autoimmune disease
- 'We Do it To Help Out:' Federal Health Care Workers Assist Local Hospitals During COVID Surge
11/19/2020: The Billings Gazette highlights the work of Debra Skoniecki and other members of federal Department of Health and Human Services Trauma and Critical Care Team, who are currently helping Billings, Montana cope with a devastating surge of COVID-19 cases
- Post-Mortem and Morbidity Studies Offer Insights into the Association of COVID-19 with Neurologic Disorders
11/19/2020: Shibani Mukerji, MD, PhD, provides Neurology Today with expert commentary on a study of neurological disorders in COVID-19 patients
- Head Injury and Persistent Headache in People Seeking Asylum: What Neurologists Need to Know
11/19/2020: Neurology Today speaks with Altaf Saadi, MD, MSc, the associate director of the Mass General Asylum Clinic, about how neurologists can help evaluate refugees for traumatic brain injuries and other neurological conditions
- NurOwn Fails to Slow Disease Progression in ALS Patients, Top-line Data Show
11/18/2020: Despite disappointing results from the largest group of patients, the NurOwn trial did show promise for some early-stage patients, and Merit Cudkowciz, MD, MSc says that “it is important to fully explore this finding"
- Telemedicine for Stroke Care and Rehabilitation
11/17/2020: The COVID-19 pandemic increased the use of telemedicine, but it's been relatively common in stroke care for decades. Lee Schwamm, MD, speaks with Everyday Health about how telestroke brings stroke experts to hospitals everywhere
- Excited Delirium Dilemma: Explanation or Excuse for In-custody Deaths?
11/16/2020: Fox Channel Nine covers the attribution of deaths in police custody to "excited delirium," a diagnosis that Mass General Neurologist Altaf Saadi, MD, MSc and others say has "no scientific basis"
- Newborn's Rare Diagnosis Amid Coronavirus a Double Whammy for Massachusetts Family
11/12/2020: Fox News speaks with Kathryn Swoboda, MD about a family whose newborn was tested and treated for the rare genetic disorder Spinal Muscular Atrophy. With early detection and treatment, "SMA children are now indistinguishable from their peers as they grow into a healthy, happy toddler,” says Dr. Swoboda
- New Data Shows Extended Survival for ALS Patients
11/9/2020: Ohio's Spectrum News 1 profiles a local ALS patient and his experience in the recent CENTAUR ALS clinical trial, and speaks with Principal Investigator Sabrina Paganoni, MD, PhD about further research
- FDA Could Move Closer to Approving First New Alzheimer's Drug in Nearly 20 Years
11/5/2020: CNN consults Rudy Tanzi, PhD about the drug approval process for a potential new Alzheimer's treatment now under consideration by the FDA
- Are Infections Seeding Some Cases of Alzheimer’s Disease?
11/4/2020: Nature magazine covers research conducted by investigators including Rudy Tanzi, PhD into a possible explanation for the development of amyloid plaques in the brains of people suffering from Alzheimer's
- Sleep Health: How These Stressful Times Affect Your Sleep & What Can Be Done To Help
10/29/2020: Maine Public Radio spoke with Aleksandar Videnovic, MD and other health experts about how sleep is integrated with overall mental and physical health and ways the pandemic is affecting people's sleep
- English Study Shows Potential Link Between Cognitive Decline and COVID-19
10/28/2020: Boston 25 News consults Shibani Mukerji, MD, PhD, about the possibility that COVID-19 infection is linked to cognitive decline. Dr. Mukerji cautions that further study will be required before we can be certain
- A DNA mystery: A woman was supposed to get Alzheimer’s by 50. Why didn’t she?
10/28/2020: The Boston Globe profiles Yakeel Quiroz, PhD and her investigation into a woman who remained healthy well into her seventies despite carrying a gene that normally causes early-onset dementia. Her research could provide clues about how to prevent Alzheimer's Disease
- 'Landmark' Study Pushed Detection of Covert Consciousness in TBI
10/28/2020: Medscape covers a presentation on breakthroughs in understanding of consciousness and traumatic brain injury by Brian Edlow, MD
- I Treated COVID Patients Last Spring. What If I've Seen Too Much To Ever Feel Normal Again?
10/27/2020: Neuro-oncologist Joshua Budhu, MD writes about the stress of preparing for a second wave of COVID-19, not knowing when or if it will strike
- Feel Woozy? Do This First
10/26/2020: The Harvard Health Letter consults Natalia Rost, MD, chief of the Mass General Stroke Service, on what to do if you feel lightheaded, confused and unsteady
- What We Know So Far about How COVID Affects the Nervous System
10/22/2020: Scientific American quotes Anne-Louise Oaklander, MD, PhD, on the intersection of neuropathy and COVID-19, a topic of increasing importance for "long-hauler" patients
- Why ‘falling back’ an hour will disrupt sleep, routines even more than usual this year
10/22/2020: Boston 25 News speaks with Mass General sleep expert Elizabeth Klerman, MD, PhD about the hazards of changing clocks twice a year for daylight savings time
- Despite Best Safety Evidence, Some Women with Neurologic Disorders Delay Pregnancy
10/22/2020: Neurology Today quotes Rebecca Burch, MD, FAHS on the importance of early discussion of family planning for patients with neurological conditions
- Harvard Professors Elected to the National Academy of Medicine
10/22/2020: Chief of Neurology Merit Cudkowicz, MD, MSc, was one of 100 people elected to the National Academy of Medicine
- COVID-19’s Impact on the Brain From a Neurologist Working the Frontlines
10/19/2020: The Women's Alzheimer's Movement interviews Marie Pasinski, MD about her experience with COVID-19 patients at the Chelsea Respiratory Infection Clinic and the McCance Center for Brain Health's COVID-19 Survivors Clinic
- Drug May Extend A.L.S. Patients’ Lives by Several Months, Study Finds
10/16/2020: The New York Times covers the results of follow-up studies on AMX0035 conducted at the Healey Center for ALS, showing that the drug may extend life as well as slow down ALS progression. The research, published in the journal Muscle and Nerve, was also the subject of announcements from Amylyx Pharmaceuticals and Mass General
- New Machine Learning Model May Help Predict Dementia, Harvard Medical School Researchers Report
10/9/2020: The Crimson reports on research into predicting dementia by data scientist Elissa Ye and Neurologist Brandon Westover, MD, PhD of the McCance Center for Brain Health
- Selective Serotonin Reuptake Inhibitor Exposure Is Associated with Greater Risk of Recurrent Hemorrhagic Stroke
10/8/2020: Neurology Today discusses research by Alessandro Biffi, MD on ways to reduce recurrent stroke and the risks posed by antidepressants
- This Portable Bedside MRI Device Has Received FDA Clearance
10/6/2020: Forbes covers the approval of a portable MRI, developed with research from Taylor Kimberly, MD, Chief of the Division of Neurocritical Care at Mass General. The new system costs less than traditional MRI devices, and doesn't require moving critically ill patients to a dedicated MRI room
- Research Findings Show Potential Promise for Slowing Down ALS
10/2/2020: CBS 58 interviews Sabrina Paganoni, MD, PhD and Justin Klee, the co-founder and co-CEO of Amylyx Pharmaceuticals, about ongoing research into a potential new ALS treatment
- Coffee Consumption Tied to Lower Risk of Developing Parkinson's Disease
10/1/2020: Coverage of a study by Grace Crotty, MBBCh, BAO into the possibility that caffeine consumption can help to lower Parkinson's risk. The study was originally published in the journal Neurology and also covered in HealthDay, MedPage Today, McKnight's Long Term Care News and StudyFinds
- The Mysterious, Multifaceted Cerebellum
9/29/2020: Knowable Magazine discussed long-running research by Jeremy Schmahmann, MD into the cerebellum's influence on emotion and cognitive function
- Glens Falls Hospital Gains Teleneurology Program in Partnership with Massachusetts General Hospital
9/29/2020: ABC News 10 covered the opening of Glens Falls Hospital's new teleneurology program and spoke with Anand Viswanathan, MD, PhD, Director of Mass General TeleStroke Services
- New Treatment Option Brings Hope to Patients with Neurological Disease
9/23/2020: ABC affiliate WCVB TV covers advances in deep brain stimulation treatment featuring Mass General neurologist Todd Herrington, MD, PhD and neurosurgeon Mark Richardson, MD, PhD
- What to Do About Racism in Medicine? These Diversity Leaders in Neurology Chart a Course with Faculty
9/17/2020: Neurology Today showcases the work of Nicte Mejia, MD, MPH, FAAN and others to enhance social justice programs at their hospitals and medical schools – and build toolkits to help others build on their achievements elsewhere
- Your Neurology Program Director Will See You Now: Tips for Showcasing Programs During a Pandemic
9/17/2020: Neurology Today highlights the way that Mass General Neurology and other programs have moved to online recruiting for fellowships
- Dosing Begins in Phase 2a Study of ALZT-OP1a for Mild-to-Moderate ALS
9/16/2020: ALS News Today covers the launch of a new clinical trial based on research from the labs of Ghazaleh Sadri-Vikili, PhD and Rudolph Tanzi, PhD
- Brown Researchers Aim to Restore Mobility by Reading People’s Minds
9/12/2020: Providence’s WPRI-TV interviewed Leigh Hochberg, MD, PhD, Director of the MGH Center for Neurotechnology and Neurorecovery, about brain-computer interfaces and BrainGate research
- Could this Portable MRI Operate Safely in Patient Rooms?
9/11/2020: Medical Design and Outsourcing coverage of study co-authored by Mass General investigator W. Taylor Kimberly, MD, PhD
- Poor Sleep Linked with Future Amyloid-β Build Up
9/11/2020: The Scientist quotes Ksenia Kastanenka, PhD on research suggesting a connection between poor sleep and Alzheimer's symptoms
- Diagnosing Tuberous Sclerosis Complex for Dermatologists
9/11/2020: The Dermatologist interviews Elizabeth Thiele, MD, PhD, director of the Carol and James Herscot Center for Tuberous Sclerosis Complex, about how dermatologists can identify this neurological condition
- 100 People Transforming Business
9/10/2020: Mass General Chief of Neurology and Director of the Healey Center for ALS Merit Cudkowicz, MD, MSc is recognized by Business Insider as one of 10 people transforming health care
- AstraZeneca's COVID-19 Vaccine Trial Has Been Stopped After an Illness
9/9/2020: USA Today quotes Anne Oaklander, MD, PhD on a probable case of transverse myelitis during a COVID-19 vaccine trial and discusses her work on the neurological complications of COVID-19
- 2 College Students Dreamed Up an A.L.S. Treatment. The Results Are In.
9/3/2020: New York Times coverage of the Healey Center's latest trial results on a new drug with major promise for ALS. The promising trial results also saw notice in numerous other publications, including Wall Street Journal, STAT News, MDAlert, MedPage Today, Neurology Live, NPR and Medscape
- SSRIs Risky After Intracerebral Hemorrhage
9/2/2020: Medscape covers research by Alessandro Biffi, MD into the risks and benefits of some antidepressants following intracerebral hemorrhage. The study was also covered by Psychiatry Advisor
- Small-Fiber Polyneuropathy May Underlie Dysautonomia in ME/CFS
9/2/2020: Medscape refers to the work of Anne-Louise Oaklander, MD, PhD when discussing neuropathy research
- Mini-Dose Edoxaban May Safely Cut AF Stroke Risk in the Frail, Very Elderly
9/1/2020: Medscape quotes Daniel Singer, MD on a new study on ways to safely reduce the risk of stroke among some patients with atrial fibrillation
- How ALS Research Shifted to Homes During the Coronavirus Pandemic
8/20/2020: Business Insider spoke with Merit Cudkowicz, MD, MSc, about the impact of the COVID-19 pandemic on clinical trials, and how the Healey Center for ALS has adapted
- Researchers Develop Tool to Predict CAR T-cell Therapy-associated Neurotoxicity
8/18/2020: Healio covers work by Daniel Rubin, MD, PhD that may help predict and prevent neurological side effects of certain cancer treatments. His work was also discussed by the American Journal of Managed Care.
- Running Miles for ALD: Grafton Father’s Mission to Fund Research
8/14/2020: Boston 25 News quotes Florian Eichler, MD about treating a patient with adrenoleukodystrophy (ALD), and the patient's family's research fundraising
- A new Approach to ALS Drug Trials Gives Patients Hope
8/12/2020: Mass General will lead the simultaneous testing of multiple potential treatments for ALS
- Aural Analytics’ Speech Technology Added to HEALEY ALS Platform Trial
8/11/2020: Aural Analytics’ speech-based digital technology will be used to measure changes in speech in people with ALS as endpoints for the HEALEY ALS Platform Trial
- Aural Analytics To Power Speech-Based Endpoints For The Healey Center ALS Platform Trial at Mass General Hospital
8/6/2020: The first-ever platform trial for ALS is set to kick off this month, led by investigators at the Sean M. Healey & AMG Center for ALS at Mass General Hospital
- This COVID-19 Practice: A Call to Limit Unnecessary Transfers to Comprehensive Stroke Centers
8/6/2020: Neurology Today quotes Lee Schwamm, MD on a dilemma facing community hospitals: should stroke patients be transferred to comprehensive stroke centers even though the transfer may increase their risk of COVID-19 exposure?
- MGH Nurses Send Meals to Fellow Nurses in Arizona, Florida
8/3/2020: The Boston Globe highlights efforts led by Neuroscience ICU nurses Lee Bodock, RN and Kim Herron, RN to show appreciation and send meals to fellow nurses working long hours in hospitals hard-hit by COVID-19
- Michael J. Fox Foundation Announces Winners of the “Ken Griffin Alpha-synuclein Imaging Competition” to Develop Game-Changing Tool for Parkinson’s Research
7/30/2020: Stephen Gomperts, MD, PhD and collaborators have won a Fox Foundation Award for their research into an imaging tracer to track Parkinson’s pathology
- Stem Cell ‘Therapy’ Injuries More Widespread Than We Knew
7/29/2020: UConn Today quotes Michael Levy, MD, PhD in an article about the risks and limitations of experimental stem cell treatments
- ‘Amazing, Isn’t It?’ Long Sought Blood Test for Alzheimer’s in Reach
7/28/2020: The New York Times quotes Mass General investigator Rodolph Tanzi, PhD, on a breakthrough in Alzheimer's diagnosis. The study, published in JAMA by authors including Yakeel Quiroz, PhD, was also covered by Advisory Board
- COVID-19 Means I Only Call Patients' Families, and My Aunt's Doctor Could Only Call Me
7/26/2020: Writing at NBCNews.com, Neuro-oncology fellow Joshua Budhu, MD reflects on the limitations of speaking to the families of patients by phone instead of in person
- Another COVID-19 Medical Mystery: Patients, Post-Ventilator, Who Don’t Wake Up
7/24/2020: WBUR speaks with Brian Edlow, MD about the profound questions surrounding persistent comatose states among intubated COVID-19 patients
- Police Keep Using ‘Excited Delirium’ to Justify Brutality. It’s Junk Science
7/17/2020: Méabh O'Hare, MB, BCh, Joshua Budhu, MD, and Altaf Saadi, MD, MSc write in the Washington Post about the misuse of medical jargon to justify police use of force. Their op-ed was also published in The Day; Drs. O'Hare and Budhu were subsequently interviewed about the issue on WGBH Radio's program Greater Boston
- UMass Medical School and Massachusetts General Hospital Target Mutant Gene that Causes ALS with MicroRNA in Breakthrough Treatment
7/10/2020: MassLive extends coverage of new advances in microRNA-based treatment of SOD1-ALS
- As the Pandemic Cancels Large In-Person Events, Neurology Conferences Go Virtual
7/9/2020: Natalia S. Rost, MD, MPH, FAAN and other experts discuss the move to an online conference format for the American Academy of Neurology
- 'First Step' Mass. Research Turns Off Key Gene In ALS That Runs In Families
7/8/2020: WBUR covers recent breakthroughs in ALS treatment using micro-RNA. The research was also covered by WHDH, CBS Local Boston and NBC Boston, which referred to the study as "Incredible Progress"
- This COVID-19 Practice: A Message on Stroke—Limit Overtriage and Unnecessary Transfers to Comprehensive Stroke Centers
7/7/2020: Neurology Today speaks with Lee Schwamm, MD and other experts about the benefits and limits of new triage and transfer guidelines for stroke patients during the COVID-19 pandemic
- Bio-IT World Announces 2020 Innovative Practices Award Winners
7/6/2020: Bio-IT World recognized the Center for Innovation and Bioinformatics at Mass General's Neurological Clinical Research Institute for its development of the SigNET Platform, which enables scientific collaboration, integration, analyses, and distribution of research data across studies and repositories
- Pains, Chills, Fatigue, Vomiting and Vertigo Plague Me. Small Fiber Neuropathy Causes it All
6/28/2020: The Washington Post consults Neuropathy Commons founder and Mass General researcher Anne Louise Oaklander, MD, PhD for an article about small fiber neuropathy
- Allen Institute will host $40.5M brain research center to map the effects of Alzheimer’s disease
6/25/2020: GeekWire covers a new research center in Seattle, advised in part by Mass General researcher and clinician Bradley Hyman, MD, PhD
- It’s a Public Health Crisis: How Systemic Racism Can Be Neurotoxic for Black Americans
6/24/2020: Research from Altaf Saadi, MD, MSc and others on the neurological and other health impacts of systemic racism gets coverage in Neurology Today
- Aiming Ultrasound at the Brain Raises Hope of New Treatments
6/24/2020: Science Magazine discusses a planned study at Mass General
- How One Man Is Using Golf to Fend off Parkinson’s Disease (and Helping Others Do the Same)
6/23/2020: Golf Magazine coverage of a clinical trial led by Anne-Marie Wills, MD, MPH, using golf as an exercise program to enhance balance and mobility for Parkinson's Disease patients
- My Friend Was Struck by ALS. Here’s How He’s Fighting Back
6/23/2020: A profile of I Am ALS founder and Healey Center for ALS patient Brian Wallach and his work to fund research on the deadly disease
- Sniff Test for Unresponsive Patients Offers New Tool for Prognosis
6/18/2020: Neurology Today speaks with Brian Edlow, MD and other researchers about a new technique that can help predict the likelihood that an unconscious brain injury patient will recover
- Negative Thinking Tied to Cognitive Decline, Alzheimer's Pathology
6/11/2020: Medscape quotes Rudy Tanzi, PhD on new research pointing to a possible new way to prevent dementia
- Sean Healey Raised Funds for Research Into ALS Treatments
6/5/2020: The Wall Street Journal quotes Merit Cudkowicz, MD, MSc, in an obituary for the fund manager and philanthropist
6/2/2020: Medicine @ Brown profiles the Brown University alumni who founded Amylyx, and how encouragement from and collaboration with Rudy Tanzi, PhD and Merit Cudkowicz, MD, MSc helped bring the pharmaceutical startup's first ALS drug to a successful clinical trial
- Alzheimer’s Tau Tracer Wins Landmark Approval
5/29/2020: MedPage Today discusses the approval of a new technology to diagnose Alzheimer's Disease using neuroimaging, with commentary from Reisa Sperling, MD, director of the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital and Massachusetts General Hospital
- Longtime AMG chief Sean Healey dies at 59 after suffering from ALS
5/28/2020: The Boston Globe reports on the passing of Sean Healey, and quotes Merit Cudkowicz, MD, MSc, about him: “He became a good friend and a partner in this fight against ALS. He’s a remarkable man. It wasn’t just about giving money. It was his intellect, it was his business acumen.”
- Boston Medical Researchers Creating Smell Test for Coronavirus
5/26/2020: The Boston Herald reports on work by Mark Albers, MD, PhD and other researchers to diagnose COVID-related loss of smell (anosmia). The test was also covered by CBS Boston and NBC Boston
- In Colombian Alzheimer’s Kindred, Blood NfL Climbs 22 Years Before Symptoms
5/26/2020: ALZForum reports on results of a decades-long study of biomarkers in families with hereditary Alzheimer's Disease, co-authored by Yakeel Quiroz, PhD
- Consensus Guideline to Help Distinguish Behavioral-Variant Frontotemporal Dementia from Psychiatric Disorders
5/21/2020: Neurology Today quotes Bradford Dickerson, MD, FAAN on work to standardize diagnosis for this type of dementia
- Health Care Disparities, Neurologic Risk Factors, and COVID-19
5/21/2020: Nicte Mejia, MD, MPH, FAAN is consulted for this Neurology Today article about the disparate impact of COVID-19 on minority populations
- The Future of ALS Clinical Trials
5/21/2020: The Connecting ALS podcast hosts Merit Cudkowicz, MD, MSc, to discuss COVID-19 and the Healey ALS Platform Trial
- 12 Emerging Technologies that Could Revolutionize Medicine
5/20/2020: MDLinx reports on the World Medical Innovation forum's Disruptive Dozen. This year's honorees include Patricia Musolino, MD, PhD, for her work on gene therapy for rare neurological diseases
- Before She Was Diagnosed With Small Fiber Polyneuropathy, Doctors Misdiagnosed This Woman's Pain for 18 Years
5/20/2020: Health.com features a patient whose confusing and painful symptoms finally got a diagnosis with help from Anne Louise Oaklander, MD
- How COVID-19 Accelerated the Rise of Telemedicine
5/18/2020: MSNBC video report features Lee Schwamm, MD and covers Mass General's role in the development of telemedicine technology
- Scientists turned Parkinson’s Disease Patient’s Skin Cells Into Brain Cells, Now He Can Tie His Shoes Again
5/14/2020: Newsweek covers a groundbreaking experimental stem cell therapy for Parkinson's Disease. Coverage also appears in Reuters, European Pharmaceutical Review and HealthDay
- All of Your Questions about Using Telehealth, Answered
5/12/2020: Boston Magazine asks Lee Schwamm, MD to answer questions many patients have about telehealth services
- Mass General expert: Virtual Care Capability Needs To Be Scaled Like the National Guard
5/11/2020: MedCity News covers remarks by Dr. Lee Schwamm, Vice President of Virtual Care and Digital Health, at the World Medical Innovation Forum
- COVID-19 Is Making America's Loneliness Epidemic Even Worse
5/8/2020: Time speaks with Rudy Tanzi, PhD about the impact of loneliness on health during social distancing
- For the first time, scientists can see how the brain records our memories as we sleep
5/8/2020: CNN discusses research led by Sydney Cash, MD and Leich Hochberg, MD, PhD illustrating a possible way that memories are encoded. The study, which monitored BrainGate clinical trial participants with paralysis and brain-computer interfaces as they learned a new task and then rested, showed that neurons "replay" newly learned activities while at rest.
The resulting paper in Cell, "Replay of Learned Neural Firing Sequences During Rest in Human Motor Cortex," has also gotten coverage in Science Daily, US News & World Report, Inverse, New Atlas, Gizmodo and NPR's Science Friday
- Study of US Veterans Points to a Connection Between Late-Onset Seizures and Dementia
5/7/2020: Neurology Today consults Andrew Cole, MD about the promise and limitations of a new study exploring the relationship between seizures and degenerative disease
- ALS Association Funding Earmarked to Improve Clinical Trial Infrastructure
5/5/2020: ALS News Today covers ALSA funding of clinical trials in a collaboration between the Healey Center for ALS, NEALS and the Barrow Neurological Institute
- Review: COVID-19 and Neuromuscular Disorders
5/1/2020: Amanda Guidon, MD, of the Mass General Myasthenia Gravis Clinic, reviews the neuromuscular impacts of COVID-19 in Advances in Motion
- The First Seven Years of NeuroNEXT
5/1/2020: Advances in Motion covers the accomplishments of the NeuroNEXT clinical trials network
- Should CBD Become Part of Your Wellness Routine?
4/20/2020: CNN talks with Elizabeth Thiele, MD, PhD, about what the trendy treatment can do, its limitations, and what we don't yet know
- How One Hospital System is Using Technology to Reduce Health Care Providers' Exposure to Coronavirus
4/19/2020: CNN Business shows how Mass General's Lee Schwamm, MD and doctors at other hospitals are using telehealth systems to reduce the risk of COVID-19 transmission